From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,810,000 shares, representing 6.03% for $74.32 million under the buyback announced on March 8, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.02 USD | -2.11% | +1.47% | -23.66% |
May. 03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
May. 03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.66% | 673M | |
-16.99% | 8.67B | |
+65.44% | 4.25B | |
-1.10% | 2.51B | |
-10.68% | 2.47B | |
-41.76% | 2.25B | |
-10.07% | 1.91B | |
-19.57% | 1.56B | |
-39.61% | 1.19B | |
+9.54% | 1.15B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.